医療薬学
Online ISSN : 1882-1499
Print ISSN : 1346-342X
ISSN-L : 1346-342X
一般論文
喘息治療薬服用患者に発症する『口腔トラブル』の規定因子の検討
―副作用回避を目指せる吸入指導構築に向けての提言―
腰山 節子
著者情報
ジャーナル フリー

2013 年 39 巻 8 号 p. 482-490

詳細
抄録
For patients receiving prescriptions of inhaled steroids, gargling after completing inhalation is necessary to prevent adverse drug reactions, including oral problems (stomatitis caused by oral candidiasis, hoarseness, and pharyngolaryngeal irritation). However, it has been reported that many patients experience oral problems despite gargling considered to be appropriate after inhalation. A possible cause of these problems is dry mouth, which is one of the adverse drug reactions to anti-allergic drugs and leukotriene receptor antagonists frequently administered concomitantly. This study evaluated the relationship between the onset of oral problems and salivary secretion. In 531 patients receiving treatment for asthma, we conducted a questionnaire survey, measured salivary secretion, and examined prognostic factors for the onset of oral problems using simple and multiple regression analyses. The results revealed significant prognostic factors before adjustment to be the number of concomitant drugs other than anti-asthma drugs and decreased salivary secretion. Furthermore, independent significant prognostic factors after adjustment were age and decreased salivary secretion.
These results suggested that oral care focusing on improvement of dry mouth and thorough instructions to younger patients would be effective for the prevention of oral problems. Based on the verification results obtained in this study, re-establishment of the current instructions for inhalation is considered to be necessary to support better treatment for asthma in the future.
著者関連情報
© 2013 日本医療薬学会
前の記事 次の記事
feedback
Top